Myelofibrosis
Showing 26 - 50 of 670
Myelofibrosis Trial in Jinan (Ruxolitinib)
Recruiting
- Myelofibrosis
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jul 3, 2022
Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)
Recruiting
- Myelofibrosis Due to and Following Polycythemia Vera
-
Basking Ridge, New Jersey
- +6 more
Jan 26, 2023
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)
Recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Fedratinib Oral Capsule [Inrebic]
- Nivolumab
-
Greifswald, Germany
- +1 more
Jun 15, 2022
Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)
Not yet recruiting
- Myelofibrosis
- TQ05105 tablets
- +2 more
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Aug 30, 2023
Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)
Active, not recruiting
- Myelofibrosis
- Chronic Myelomonocytic Leukemia
-
Duarte, California
- +9 more
Jan 24, 2023
Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)
Not yet recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablets
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Nov 9, 2023
Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,
Active, not recruiting
- Acute Leukemia
- +4 more
- Fludarabine
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)
Not yet recruiting
- Myelofibrosis
- TQ05105 Tablets
- TQB3617 Capsules
-
Guangzhou, Guangdong, China
- +19 more
Nov 7, 2023
AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)
Not yet recruiting
- AML
- +5 more
- Infusion of CD34 selected hematopoietic stem cells
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Sep 14, 2023
Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)
Active, not recruiting
- Myelofibrosis
-
Middletown, New Jersey
- +6 more
Aug 23, 2022
Myelofibrosis Trial in Houston (CK0804)
Not yet recruiting
- Myelofibrosis
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jun 28, 2022
Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)
Terminated
- Essential Thrombocythemia
- +2 more
- Arsenic Trioxide
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis
Recruiting
- Myelofibrosis
- Hematopoietic Stem Cell Transplant
-
Minneapolis, MinnesotaCenter for International Blood and Marrow Transplant Research
Mar 17, 2022